Blog

Why this startup is playing in one of the hottest areas of cancer – San Francisco Business Times


San Francisco Business Times

Why this startup is playing in one of the hottest areas of cancer
San Francisco Business Times
A San Francisco startup cofounded by a cancer immunotherapy pioneer, a serial entrepreneur with a winning record and a former Genentech Inc. researcher is heading into one of drug development's hottest spaces with a fresh round of $62 million. Pionyr

and more »

2017-12-13 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.